摘要
目的:为促进我国网上药店的发展提供参考。方法:根据文献,对我国网上药店的现状、发展瓶颈,建立统一电子交易平台的必要性、可行性以及发展模式进行分析。结果与结论:截至2011年9月22日,我国批准的网上药店共48家,而正式经营的仅十余家。我国网上药店统一电子交易平台存在未与医疗保障体系对接、有影响力的品牌或航母级网上药店缺失等主要发展瓶颈。我国网上药店统一电子交易平台的建立利于医药企业低成本开拓网上零售市场、利于消费者比较药品价格及提升消费者对网上药店的忠诚度、利于政府部门对网上药品零售购销行为的监督管理以及利于创建网上药店品牌网站,且在技术、经济、运行上是可行的。我国网上药店统一电子交易平台可以通过联盟模式和第三方模式来加快发展,提升整体服务水平。
OBJECTIVE： To provide reference to promote the development of online pharmacies in China. METHODS： The situation and development bottle neck of online pharmacy in China and the necessity, feasibility and development mode of unified electronic trading platform were analyzed according to literature study. RESULTS ＆ CONCLUSIONS： Up to Sept. 22th, 2011, a total of 48 online pharmacies have been approved, while only 10 pharmacies run formally. The main development bottlenecks of online pharmacies in China are that online pharmacy electronic trading platform hadn＇t been coupled with online medicare payment system, and there was lack of the influential brand or aircraft carder class online pharmacies. The establishment of unified electronic trading platforms of online pharmacy contributes to online retail market development with low cost by pharmaceutical enterprise, to the drug price compared by consumers and loyalty of consumer to online pharmacy, to the supervision of the government depart- ments on online drug retail and purchase behavior, and to creating online pharmacies brand website, and it is feasible in the fields of technology, economy and operation. China＇ s online pharmacies unified electronic trading platform can speed up development and improve the whole level of service through the alliance mode and the third party mode.
出处
《中国药房》
CAS
CSCD
2012年第13期1245-1248,共4页
China Pharmacy
关键词
网上药店
统一电子交易平台
探讨
联盟模式
第三方模式
Online pharmacy
Unified electronic trading platform
Exploration
Alliance mode
The third party mode
